REUTERS: With Pfizer and BioNTech's COVID-19 vaccine distribution imminent after US authorisation on Friday (Dec 11), top regulators sought to reassure Americans that the record fast pace was warranted and had not sacrificed safety.

"We worked quickly based on the urgency of this pandemic, not because of any other external pressure," US Food and Drug Administration Commissioner Stephen Hahn said during a press conference.